References

1. SperoffL, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:187-232, 401-463.

2. Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: A study of 262 patients. Am J Obstet Gynecol 1986;155(3):531-543.

3. Barbeiri RL, Ryan KJ. The menstrual cycle. In: Ryan Kistner's Gynecology and Women's Health. 7th ed. St. Louis, MO: Mosby, 1999:23-57.

4. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR. Abnormal uterine bleeding: Ovulatory and anovulatory dysfunctional uterine bleeding, management of acute and chronic excessive bleeding. In: Comprehensive Gynecology. 4th ed. St. Louis, MO: Mosby, 2001:1079-1097.

5. American College of Obstetricians and Gynecologists. Management of anovulatory bleeding. ACOG Practice Bulletin Number 14. Obstet Gynecol 2000(Mar):495-502.

6. SperoffL, Glass RH, KaseNG. Clinical gynecologic endocrinology and infertility. 6th ed. Baltimore, MD: Lippincott Williams & Wilkins, 1999:487-511.

7. American College of Obstetricians and Gynecologists. Polycystic ovary syndrome. ACOG Practice Bulletin Number 41. Obstet Gynecol 2002;100:1389-1402.

8. Adams Hillard PJ, Deitch HR. Menstrual disorders in the college age female. Pe-diatr Clin N Am 2005;52(1):179-197.

9. Gordon CM, Nelson LM. Amenorrhea and bone health in adolescents and young women. Curr Opin Obstet Gynecol 2003;15:377-384.

10. Pletcher JR, Slap GB. Menstrual disorders—Amenorrhea. Pediatr Clin N Am 1999;46(3):505-518.

11. French L. Dysmenorrhea. Am Fam Physician 2005;71:285-292.

12. Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Safety 2004;27(2):75-90.

13. Munro MG, Mainor N, Basu R, et al. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: A randomized clinical trial. Obstet Gynecol 2006;108:924-929.

14. Harel Z. A contemporary approach to dysmenorrhea in adolescents. Pediatr Drugs 2002;4(12):797-805.

15. Simon JA. Progestogens in the treatment of secondary amenorrhea. J Reprod Med 1999;44:185-189.

16. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: Measured blood loss, clinical features, and outcome in women with heavy periods: A survey with follow-up data. Am J Obstet Gynecol 2004;190(5):1216-1223.

17. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia II: Is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol 2004;190(5):1224-1229.

18. Dickersin K, Munro MG, Clark M, et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: A randomized controlled trial. Obstet Gynecol 2007;110(6):1279-1289.

19. Prentice A. Fortnightly review: Medical management of menorrhagia. BMJ 1999;319(7221):1343-1345.

20. Reid PC, Virtanen-Kari S. Randomized comparative trial of levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: A multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. Br J Obstet Gynecol 2005;112:1121-1125.

21. American College of Obstetricians and Gynecologists. Noncontraceptive uses of the levonorgestrel intrauterine system. ACOG Committee Opinion Number 337. Obstet Gynecol 2006(June);107:1479-1482.

22. American College of Obstetricians and Gynecologists. Intrauterine device. ACOG Practice Bulletin No. 59. Obstet Gynecol 2005;105:223-232.

23. Hurskainen R, Paavonen J. Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 2004;16:487-490.

24. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment ofmen-orrhagia: Randomized trial 5-year follow-up. JAMA 2004;291(12):1456-1463.

25. Dawood MY. Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol 2006;108:428-441.

26. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR. Primary and secondary dysmenorrhea and premenstrual syndrome etiology, diagnosis, and management. In: Stenchever MA, ed. Comprehensive Gynecology. 4th ed. St. Louis, MO: Mosby, 2001:1065-1078.

27. American College of Obstetricians and Gynecologists. Menstruation in girls and adolescents: Using the menstrual cycle as a vital sign. ACOG Committee Opinion Number 349. American Academy of Pediatrics; American College of Obstetricians and Gynecologists. Obstet Gynecol 2006(Nov);108:1323-1328.

28. Guzick DS. Polycystic ovary syndrome. Am J Obstet Gynecol 2004;103(1):181-192.

29. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.

30. Buggs C, Rosenfield, RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin N Am 2005;34:677-705.

31. Mathur R, Levin O, Azziz R. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag 2008;4(2):487-492.

32. Creanga AA, Bradley HM, McCormick C, et al. Use of metformin in polycystic ovary syndrome: A meta-analysis. Obstet Gynecol 2008;111(4):959-968.

33. Khorram O, Helliwell JP, Katz S, et al. Two weeks of metformin improves clomi-phene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome. Fertil Steril 2006;85(5):1448-1451.

Pregnancy Nutrition

Pregnancy Nutrition

Are You Expecting? Find Out Everything You Need to Know About Pregnancy and Nutrition Without Having to Buy a Dictionary. This book is among the first books to be written with the expertise of a medical expert and from the viewpoint of the average, everyday, ordinary,

Get My Free Ebook


Post a comment